Le Lézard
Classified in: Health
Subject: AWD

Bracket Patient Engagement and eCOA Innovator Jeff Lee Named to PharmaVOICE 100 Most Inspirational People 2018


KING OF PRUSSIA, Pa., Aug. 2, 2018 /PRNewswire-PRWeb/ -- Bracket, a technology company providing solutions for better patient outcomes and actionable insights, is honored to announce patient-centric innovator Jeff Lee has been named one of the PharmaVOICE 100 most inspirational people in the life sciences industry. As President, eCOA, Patient Engagement at Bracket, Lee is dedicated to building solutions that deliver an outstanding user experience, transforming the way patients participate in clinical research.

For more than a dozen years, PharmaVOICE magazine has recognized the most inspirational, motivational, and transformational individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue. As always, this year's distinguished honorees were nominated by thousands of PharmaVOICE readers and were selected for inclusion based on how they inspire others, their positive impact on patients and the industry at large, their innovative thinking, their mentorship to the next generation of leaders, and their willingness to give their time and resources to their communities and philanthropic causes.

"I am humbled and honored to be recognized among such a worthy group of inspiring people by PharmaVOICE, especially because nominations come from clinical operations leads who use and value our solutions," said Lee. "It's crucial to be able to put yourself in the mindset of the patient, the research site, the client, employees - or even business partners. This allows for insight and collaboration that many people just don't unlock. Empathy is a secret weapon for success."

Lee founded mProve Health in 2010 to improve the patient experience in clinical trials with a BYOD philosophy that makes it easy for patients to stay invested in the study. mProve quickly became a leading provider of patient engagement and eCOA solutions on mobile devices, and was acquired by Bracket in 2017.

"Jeff's entrepreneurial spirit, visionary approach, and clinical trial expertise all in pursuit of bringing much-needed treatments to patients epitomize what it means to be a PharmaVOICE 100," says Taren Grom, editor and co-founder, PharmaVOICE. "In addition, he is an inspirational leader who is lifting his teams to new heights in their pursuit to make a difference in the industry."

Today, 18 of the top 20 pharmaceutical companies currently use Bracket technology solutions to manage their clinical trials. The company's patient engagement solutions are designed to help study sponsors and CROs improve retention rates in clinical trials, increase compliance to study protocols, and ensure adherence to therapy.
Lee is listed amongst the commanders and chiefs in the PharmaVOICE 100 issue. Read his full profile here.

About Bracket:

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

 

SOURCE Bracket Patient Engagement


These press releases may also interest you

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...

at 09:30
PossibleNOWtm, the leading provider of enterprise consent and preference management solutions, today announced the launch of a program to enable companies to quickly capture express written consent. This will provide the ability for Third-Party...

at 09:30
Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study...

at 09:30
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the...

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...

at 09:18
PRUVN Research LLC, [PRUVN], a leading research organization validating wellness products and services, is excited to announce the results of its recent preliminary study with Max International, investigating the impact of RiboCeinetm supplementation...



News published on and distributed by: